Barcelona, Spain

Julio Castro

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Artax Biopharma Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julio Castro. Retrieved from https://idiyas.com/inventor/julio-castro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Julio Castro: Innovator in Biopharmaceuticals

Introduction

Julio Castro is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of biopharmaceuticals, holding a total of 4 patents. His work focuses on innovative compounds that have the potential to impact medical treatments.

Latest Patents

Among his latest patents, Julio has developed chromene derivatives that serve as inhibitors of TCR-Nck interaction. The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same. This groundbreaking work has the potential to advance therapeutic strategies in immunology.

Career Highlights

Julio Castro is currently associated with Artax Biopharma Inc., where he continues to push the boundaries of biopharmaceutical research. His expertise and innovative approach have positioned him as a key player in the industry.

Collaborations

Throughout his career, Julio has collaborated with notable professionals, including Andrés Gagete Mateos and Peter J Machin. These partnerships have fostered a dynamic environment for innovation and development in his field.

Conclusion

Julio Castro's contributions to biopharmaceuticals through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…